Who invested in Hydra Biosciences

5 rounds we have observed, with the 10 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$95Mraised across 5 rounds since 2002, from 5 sources

$9.3MSeries A$19MSeries B$34MSeries C$22MSeries D$11MSeries E

Latest round: Series E, $11MMar 2015
Biggest round: $34MSeries C · Mar 2008
Investors: 10

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2002200420062008201020122014

$9.3MSeries A$19MSeries B$34MSeries C$22MSeries D$11MSeries E

First round: Series A, $9.3M
Biggest round: $34M
Usual gap between rounds: 4.2 years

The rounds

Mar 2015
Series E$11M
No investor was named in the report.
From a historical funding recordSEC filing: $11M sold, first sale Mar 2015
Jan 2009
Series D$22M1 new
- MedImmune Ventures
Reported by reuters.com
Mar 2008
Series C$34M1 new5 returning
From a historical funding record
Jan 2004
Series B$19M3 new5 returning
- New Enterprise Associates
- Polaris Partners
- Advanced Technology Ventures
- Abingworth
- Bioventures Investors
- Boston Medical Investors
- Lilly BioVentures
- Abbott Laboratories
From a historical funding record
Jul 2002
Series A$9.3M5 new
From a historical funding record

Founders and team

From the SEC filings it signed: 1 on the team.

Russell HerndonExecutive Officer, Directori

On the board, as filediPaul GoldenheimRobert CarpenterSteven HallVincent Miles

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2002Series B2004Series C2008Series D2009Series E2015

New Enterprise Associates

Polaris Partners

Advanced Technology Ventures

Abingworth

Bioventures InvestorsBoston Medical InvestorsMedImmune Ventures

Lilly VenturesLilly BioVenturesAbbott Laboratories

Everyone who backed them

New Enterprise AssociatesVC firm3rounds

Polaris PartnersVC firm3rounds

Advanced Technology VenturesVC firm3rounds

AbingworthVC firm3rounds

Bioventures InvestorsPrivate equity2rounds

Boston Medical InvestorsVC firm2rounds

MedImmune VenturesCorporate VC1round

Lilly VenturesGrowth equity1round

Lilly BioVenturesGrowth equity1round

Abbott Laboratoriesno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Hydra Biosciences as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Lightstone VenturesVC firmPer its own site

Quick answers about Hydra Biosciences

Who invested in Hydra Biosciences?

Hydra Biosciences's investors include New Enterprise Associates, Polaris Partners, Advanced Technology Ventures, Abingworth and Bioventures Investors, and 5 more on record.

How much has Hydra Biosciences raised?

Hydra Biosciences has raised $95M across 5 rounds since 2002.

When did Hydra Biosciences last raise?

Hydra Biosciences's most recent round was a Series E of $11M in Mar 2015.

What was Hydra Biosciences's biggest round?

Hydra Biosciences's largest round on record is $34M (Series C), in Mar 2008.

Who backed Hydra Biosciences first?

Hydra Biosciences's first round on record, in Jul 2002, was backed by New Enterprise Associates, Polaris Partners and Advanced Technology Ventures and 2 others.